BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35355680)

  • 1. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice.
    Zhou H; Tu C; Yang P; Li J; Kepp O; Li H; Zhang L; Zhang L; Zhao Y; Zhang T; Sheng C; Wang J
    Oncoimmunology; 2022; 11(1):2057892. PubMed ID: 35355680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
    Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosis.
    Huang Q; Hu J; Chen L; Lin W; Yang J; Hu W; Gao J; Zhang H; Lu JJ; Kong L
    Cancer Immunol Immunother; 2023 Dec; 72(12):4077-4088. PubMed ID: 37777634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence that carbon-ion radiotherapy utilizes cytotoxic T lymphocyte-mediated anti-tumor immunity for shrinking tumors compared to X-ray therapy.
    Takeshima T; Hirayama R; Hasegawa S
    Biochem Biophys Res Commun; 2024 Jul; 718():150058. PubMed ID: 38729076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy.
    Maines LW; Keller SN; Smith CD
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation.
    Ando K; Fujita H; Hosoi A; Ma L; Wakatsuki M; Seino KI; Kakimi K; Imai T; Shimokawa T; Nakano T
    J Radiat Res; 2017 Jul; 58(4):446-455. PubMed ID: 28339788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases.
    Eek Mariampillai A; Hauge S; Kongsrud K; Syljuåsen RG
    Front Immunol; 2023; 14():1138920. PubMed ID: 37346039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
    Hou C; Shi S; Gao M; Ji J; Ma C; Wang T; Chen T; Liu Y; Zhong J; Zheng Y; Ye J; Ke Y
    J Neurooncol; 2023 Oct; 165(1):79-90. PubMed ID: 37819535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
    Hu W; Pei Y; Ning R; Li P; Zhang Z; Hong Z; Bao C; Guo X; Sun Y; Zhang Q
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4533-4545. PubMed ID: 36138265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
    Spina CS; Tsuruoka C; Mao W; Sunaoshi MM; Chaimowitz M; Shang Y; Welch D; Wang YF; Venturini N; Kakinuma S; Drake CG
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):813-818. PubMed ID: 33190969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
    Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
    J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo.
    Sha X; Xu X; Liao S; Chen H; Rui W
    Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.
    Kroon P; Gadiot J; Peeters M; Gasparini A; Deken MA; Yagita H; Verheij M; Borst J; Blank CU; Verbrugge I
    Cancer Immunol Immunother; 2016 Jun; 65(6):753-63. PubMed ID: 27160390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.
    Kofla G; Radecke C; Frentsch M; Walther W; Stintzing S; Riess H; Bullinger L; Na IK
    Oncoimmunology; 2022; 11(1):2068109. PubMed ID: 35496500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma.
    Cavalieri S; Ronchi S; Barcellini A; Bonora M; Vischioni B; Vitolo V; Villa R; Del Vecchio M; Licitra L; Orlandi E
    Radiother Oncol; 2021 Nov; 164():1-5. PubMed ID: 34506831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.
    Li Y; Zhang H; Li Q; Zou P; Huang X; Wu C; Tan L
    Cancer Lett; 2020 Dec; 495():12-21. PubMed ID: 32941949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.
    Oweida A; Hararah MK; Phan A; Binder D; Bhatia S; Lennon S; Bukkapatnam S; Van Court B; Uyanga N; Darragh L; Kim HM; Raben D; Tan AC; Heasley L; Clambey E; Nemenoff R; Karam SD
    Clin Cancer Res; 2018 Nov; 24(21):5368-5380. PubMed ID: 30042205
    [No Abstract]   [Full Text] [Related]  

  • 19. TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma.
    Reilley MJ; Morrow B; Ager CR; Liu A; Hong DS; Curran MA
    J Immunother Cancer; 2019 Nov; 7(1):323. PubMed ID: 31771649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon ion radiotherapy boosts anti-tumour immune responses by inhibiting myeloid-derived suppressor cells in melanoma-bearing mice.
    Zhou H; Yang P; Li H; Zhang L; Li J; Zhang T; Sheng C; Wang J
    Cell Death Discov; 2021 Nov; 7(1):332. PubMed ID: 34732697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.